HPV-Associated Cancers and Precancers
10 questions
Questions in Topic
- 1. Cervical Cancer Epidemiology in United States
- 2. Initiating Cervical Cancer Screening
- 3. Cervical Cancer Screening Intervals and Methods
- 4. Discontinuing Cervical Cancer Screening
- 5. Populations Exempt from Cervical Cancer Screening
- 6. Cervical Cancer Screening in Women with HIV
- 7. Discordant Cervical Cytology and HPV Test Results
- 8. Epidemiology of Anal Cancer
- 9. Anal Cancer Screening
- 10. Epidemiology of Oral Cancer
Learning Objectives
- Summarize the impact of human papillomavirus (HPV)-related cancers in the United States
- Discuss the approach to women who have discordant cervical cytology and high-risk HPV test results
- Provide appropriate cervical cancer screening for women aged 21–65 years
- Adjust intervals for cervical cancer screening based on the woman’s age and prior screening results
- Screen for anal cancer based on the International Anal Neoplasia Society Consensus Guidelines
Authors
3rd Edition
This is a substantial revision of the original Question Bank Topic. The previous edition was titled HPV-Associated Cancers and Precancers 2 Edition Question Bank CoC and available until March 31st, 2025.
CNE/CME
Continuing Education
This lesson qualifies for:
View CE Notices
- 1.0 CME AMA PRA Category 1 Credit™, or
- 1.0 CNE contact hour and 1.0 CE contact hour (does NOT qualify for pharmacology CE for advanced practice nurses)
CNE and CME Origination: October 21st, 2022
CNE and CME Review: April 1st, 2025
CNE and CME Expiration: March 31st, 2027 (3rd Edition)
View CE Notices
Steps to acquire a Certificate for this Lesson:
1
Answer Questions
Answer the board-review style questions
2
Answer Correctly
Score 80%+
3
Give Feedback
Complete survey
4